Kingchem (Liaoning) Life Science Co., Ltd. (301509.SZ)
- Previous Close
30.66 - Open
32.50 - Bid 30.51 x --
- Ask 30.53 x --
- Day's Range
29.53 - 31.18 - 52 Week Range
22.10 - 42.68 - Volume
9,524,760 - Avg. Volume
3,762,199 - Market Cap (intraday)
3.768B - Beta (5Y Monthly) --
- PE Ratio (TTM)
58.60 - EPS (TTM)
0.52 - Earnings Date --
- Forward Dividend & Yield 0.80 (2.61%)
- Ex-Dividend Date May 9, 2024
- 1y Target Est
--
Kingchem (Liaoning) Life Science Co., Ltd. operates as a CDMO company for pharmaceutical, electronic chemicals, and fine and specialty chemicals sectors in China and internationally. The company offers alkanes, aromatic, compounds, trifluoromethoxybenzenes, fluorobenzenes, pyrrolidines, trifluorotoluenes, indenes, isoquinolines, piperidines, naphthalenes, piperazines, pyranes, isocyanates, pyrazines, pyridines, quinoxalines, pyrimidines, indanones, purines, thiophenes, phenanthrolines, carbazoles, thiomorpholines, morpholines, triazoles, imidazoles, pyrazoles, quinolines, benzofurans, indoles, tetralones, fluorinated reagents, and other fluorinated compounds. Kingchem (Liaoning) Life Science Co., Ltd. was founded in 2009 and is based in Fuxin, China.
www.kingchemchina.com--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: 301509.SZ
View MorePerformance Overview: 301509.SZ
Trailing total returns as of 4/28/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 301509.SZ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 301509.SZ
View MoreValuation Measures
Market Cap
3.69B
Enterprise Value
3.23B
Trailing P/E
58.96
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
7.21
Price/Book (mrq)
1.68
Enterprise Value/Revenue
5.88
Enterprise Value/EBITDA
42.61
Financial Highlights
Profitability and Income Statement
Profit Margin
12.62%
Return on Assets (ttm)
1.86%
Return on Equity (ttm)
3.16%
Revenue (ttm)
549.02M
Net Income Avi to Common (ttm)
69.29M
Diluted EPS (ttm)
0.52
Balance Sheet and Cash Flow
Total Cash (mrq)
470.72M
Total Debt/Equity (mrq)
0.21%
Levered Free Cash Flow (ttm)
205.45M